GFAP and Parkinson disease: In mice with PD induced by MPTP, co-administration of caffeine results not only in functional protection but an attenuation of dopaminergic neuronal degeneration as assessed by TH protein levels as a marker of dopaminergic function and glial fibrillary acidic protein (GFAP) as a marker of gliosis [37], as shown in Figure 3.